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IGF-1 ENHANCES THE OSTEOGENIC ACTIVITY OF BMP-6 IN VITRO AND IN VIVO, AND 
TOGETHER HAVE A STRONGER OSTEOGENIC EFFECT THAN WHEN IGF-1 IS COMBINED 
WITH BMP-2. 
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Bone morphogenetic protein-2 (BMP-2) is widely used in orthopedic surgery and bone tissue 
engineering because of its strong osteogenic activity. However, BMP-2 treatments have 
several drawbacks and alternatives are being explored. Since BMP-6 has been demonstrated to 
be more osteoinductive, its use, either alone or together with other cytokines, might be an 
interesting option.  
 
We have compared the effect of BMP-2, BMP-6, or insulin-like growth factor-1 (IGF-1), either 
alone or in combination. MC3T3-E1 cells were treated with IGF-1 and/or of BMP-2 or -6 and 
the expression of osteogenic genes, proliferation and alkaline phosphatase (ALP) activity in 
vitro were analyzed. The results showed that IGF-1 greatly enhanced the BMP-induced 
osteogenic differentiation of these cells and that the ALP activity in the cultures was higher 
when the combination was made with BMP-6 than with BMP-2. Other in vitro experiments 
showed that the osteogenic effect of these combinations can be modulated controlling the 
sequential administration of the growth factors.  
 
Furthermore, we have tested the osteogenic potential of these treatments in vivo by loading 
them onto absorbable collagen sponges which were implanted into an ectopic bone formation 
model in rats. These experiments revealed that only BMP-6 was able to induce bone formation 
at the used dose and that the addition of IGF-1 contributed to an increase of the 
mineralization in the implants.  
 
Hence, the combination of BMP-6 with IGF-1 might be a better alternative than BMP-2 for 
orthopedic surgery and bone tissue engineering approaches with potential application through 
using controlled delivery systems. 
